Marksans Pharma Ltd
NSE: MARKSANS BSE: 524404
₹172.95
(-0.64%)
Wed, 18 Mar 2026, 10:44 am
Market Cap78.85B
PE Ratio21.75
Dividend0.46
Health Technology
Pharmaceuticals: Major
24.5KMarksans Pharma Financials
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 2.90B | 2.32B | 2.57B | 3.56B | 3.59B | 3.05B | 3.55B | 4.37B | 6.28B | 7.94B | 8.83B | 7.67B | 9.05B | 9.89B | 11.30B | 13.70B | 14.82B | 18.51B | 21.76B | 26.17B |
| Gross profit | 575.34M | 372.67M | 223.19M | 520.30M | 494.46M | 476.18M | 507.40M | 935.32M | 1.49B | 2.13B | 1.68B | 680.11M | 1.54B | 2.17B | 2.88B | 4.91B | 4.37B | 5.96B | 7.02B | 8.65B |
| Operating expenses (excl. COGS) | -221.74M | -299.41M | -4.24M | -387.02M | -407.47M | -526.23M | -303.61M | -445.51M | -524.43M | -498.25M | -734.58M | -651.85M | -1.09B | -1.19B | -1.27B | -1.92B | -2.31B | -2.96B | -3.16B | -4.19B |
| Selling/general/admin expenses, total | -220.49M | -297.32M | — | -385.67M | -407.47M | -526.23M | -301.56M | -438.47M | -513.33M | -490.72M | -726.30M | -644.25M | -1.07B | -1.17B | -1.24B | -1.90B | -2.28B | -2.93B | -3.13B | -4.15B |
| Research & development | -50.04M | -54.18M | -2.40M | -559.01K | -496.10K | — | — | — | — | — | -76.81M | -45.31M | -52.66M | -57.13M | -83.15M | -127.49M | -297.89M | -148.97M | -199.32M | -322.98M |
| Selling/general/admin expenses, other | -170.45M | -243.13M | — | -385.11M | -406.98M | -526.23M | -301.56M | -438.47M | -513.33M | -490.72M | -649.49M | -644.25M | -1.07B | -1.11B | -1.16B | -1.77B | -1.99B | -2.78B | -2.93B | -3.83B |
| Other operating expenses, total | -1.25M | -2.09M | -4.24M | -1.35M | 0 | 0 | -2.05M | -7.03M | -11.10M | -7.53M | -8.28M | -7.60M | -25.00M | -24.50M | -21.22M | -22.48M | -24.40M | -24.65M | -33.65M | -32.14M |
| Operating income | 353.59M | 73.26M | 218.94M | 133.28M | 86.98M | -50.05M | 203.79M | 489.82M | 967.41M | 1.63B | 943.04M | 28.26M | 443.40M | 979.09M | 1.62B | 2.99B | 2.06B | 3.00B | 3.86B | 4.47B |
| Non-operating income, total | -40.78M | 17.93M | -15.66M | -204.63M | -179.25M | -2.10B | -1.95B | -54.34M | -103.30M | -68.14M | 125.46M | 120.71M | 54.58M | 63.98M | -46.11M | 34.78M | 411.62M | 378.41M | 372.49M | 572.88M |
| Interest expense, net of interest capitalized | -105.66M | -115.02M | -118.55M | -213.59M | -192.31M | -200.32M | -134.72M | -114.53M | -191.33M | -145.24M | -101.55M | -67.88M | -102.20M | -96.55M | -87.46M | -79.86M | -84.46M | -91.28M | -112.03M | -116.60M |
| Interest capitalized | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | 0 |
| Non-operating income, excl. interest expenses | 64.88M | 132.95M | 102.89M | 8.96M | 13.07M | -1.90B | -402.77M | 60.18M | 88.03M | 132.99M | 226.97M | 187.70M | 156.28M | 158.38M | 41.86M | 98.39M | 438.69M | 577.71M | 441.02M | 706.79M |
| Non-operating interest income | 0 | 0 | 0 | 76.36M | 15.44M | 17.44M | 20.25M | 9.97M | 7.20M | 32.76M | 24.79M | 2.44M | 1.06M | 571.04K | 1.00M | 11.59M | 59.73M | 120.37M | 337.87M | 301.97M |
| Miscellaneous non-operating expense | 64.88M | 132.95M | 102.89M | -67.39M | -2.37M | -1.92B | -423.03M | 50.21M | 80.83M | 100.23M | 202.18M | 185.25M | 155.22M | 157.81M | 40.86M | 86.80M | 378.96M | 457.34M | 103.15M | 404.82M |
| Unusual income/expense | — | — | — | — | — | — | -1.42B | — | — | -55.89M | 40.84K | 897.08K | 498.74K | 2.15M | -501.58K | 16.25M | 57.39M | -108.02M | 43.50M | -17.31M |
| Pretax income | 312.81M | 91.19M | 203.28M | -71.34M | -92.27M | -2.15B | -1.75B | 435.47M | 864.11M | 1.56B | 1.07B | 148.97M | 497.98M | 1.04B | 1.57B | 3.02B | 2.48B | 3.38B | 4.24B | 5.04B |
| Taxes | -83.90M | -24.26M | -46.09M | -8.20M | -3.95M | -64.14M | -10.76M | 52.79M | -127.87M | -439.21M | -241.08M | -35.63M | -139.97M | -238.69M | -364.19M | -636.26M | -606.97M | -723.32M | -1.09B | -1.21B |
| Non-controlling/minority interest | 0 | -931.71K | -3.00M | -4.01M | -4.22M | -13.87M | -27.60M | -29.42M | -17.17M | -25.67M | -42.31M | -24.96M | -28.61M | -39.77M | -37.33M | -25.99M | -22.45M | 9.87M | -11.95M | -20.44M |
| After tax other income/expense | 0 | 0 | 0 | 0 | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | 228.91M | 66.00M | 154.18M | -83.55M | -100.43M | -2.23B | -1.79B | 458.84M | 719.08M | 1.09B | 785.12M | 88.39M | 329.40M | 764.60M | 1.17B | 2.36B | 1.85B | 2.66B | 3.14B | 3.81B |
| Net income | 228.91M | 66.00M | 154.18M | -83.55M | -100.43M | -2.23B | -1.79B | 458.84M | 719.08M | 1.09B | 785.12M | 88.39M | 329.40M | 764.60M | 1.17B | 2.36B | 1.85B | 2.66B | 3.14B | 3.81B |
| Dilution adjustment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8.75M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | 228.91M | 66.00M | 154.18M | -83.55M | -100.43M | -2.23B | -1.79B | 458.84M | 719.08M | 1.09B | 785.12M | 88.39M | 329.40M | 764.60M | 1.17B | 2.36B | 1.85B | 2.66B | 3.14B | 3.81B |
| Basic earnings per share (Basic EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA | 440.80M | 154.94M | 319.96M | 292.87M | 244.47M | 151.63M | 440.91M | 646.32M | 1.12B | 1.79B | 1.22B | 329.19M | 711.79M | 1.21B | 1.88B | 3.35B | 2.51B | 3.52B | 4.61B | 5.30B |
| EBIT | 353.59M | 73.26M | 218.94M | 133.28M | 86.98M | -50.05M | 203.79M | 489.82M | 967.41M | 1.63B | 943.04M | 28.26M | 443.40M | 979.09M | 1.62B | 2.99B | 2.06B | 3.00B | 3.86B | 4.47B |
| Total operating expenses | -2.55B | -2.24B | -2.36B | -3.43B | -3.51B | -3.10B | -3.34B | -3.88B | -5.32B | -6.31B | -7.89B | -7.64B | -8.61B | -8.91B | -9.68B | -10.71B | -12.75B | -15.52B | -17.90B | -21.71B |
| Prepaid expenses | 117.18M | 0 | 0 | 0 | — | — | — | — | — | — | — | — | — | — | — | — | — | 198.04M | 251.26M | 302.63M |
| Deferred income, current | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 5.68M | 17.39M | 9.09M | 21.22M | 12.78M |
| Capital and operating lease obligations | 0 | 0 | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 93.26M | 414.34M | 414.34M | 656.89M | 1.90B | 2.63B |
| Operating lease liabilities | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Deferred tax liabilities | 56.99M | 84.99M | 108.61M | 119.59M | 122.09M | 157.11M | 130.60M | 129.82M | 130.62M | 29.75M | 28.52M | 67.50M | 60.11M | 70.29M | 125.11M | 80.63M | 176.21M | 272.10M | 292.93M | 290.15M |
| Deferred income, non-current | — | — | — | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | — | — | — | — | — | — |
| Minority interest | 0 | -434.10K | 2.68M | 6.90M | 9.14M | 25.11M | 56.16M | 69.90M | 66.36M | 81.00M | 83.61M | 62.47M | 95.49M | 102.17M | 131.10M | 188.57M | 207.01M | 199.10M | 208.52M | 224.70M |
| Change in accrued expenses | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Common dividends paid | — | — | 0 | -5.46M | — | 0 | -2.69M | -46.79M | -104.24M | -60.97M | -179.61M | -170.52M | -24.63M | -44.44M | -295.03M | -40.93M | -105.83M | -101.71M | -226.58M | -271.90M |
| Preferred dividends paid | 0 | 0 | 0 | 0 | — | — | 0 | 0 | 0 | -8.75M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800